시간 외 거래: 70.88

Nuvalent Inc (NUVL)

Nuvalent Inc 주식(NUVL)의 최신 뉴스

Nuvalent Inc (NUVL)

Nuvalent Inc 주식(NUVL)의 최신 뉴스

Wedbush Reiterates Outperform Rating for Nuvalent (NASDAQ:NUVL) - Defense World

Nuvalent director Conley Emily sells shares worth $345k - Investing.com

Wedbush Reaffirms "Outperform" Rating for Nuvalent (NASDAQ:NUVL) - MarketBeat

Nuvalent’s NVL-655 Granted Breakthrough Therapy Designation By FDA - Contract Pharma

FDA grants breakthrough therapy status for Nuvalent's NVL-655 - Yahoo Finance

Nuvalent, Inc. (NASDAQ:NUVL) Director Sells $2469000.00 in Stock - Defense World

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 - Citizentribune

FDA grants breakthrough status to Nuvalent's lung cancer drug By Investing.com - Investing.com

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 - BioSpace

Nuvalent gains breakthrough therapy status for non-small cell lung cancer candidate - Seeking Alpha

Nuvalent Gets FDA Breakthrough Therapy Designation for Lung-Cancer Treatment - MarketWatch

Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 - PR Newswire

Nicholas Investment Partners LP Cuts Position in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Nuvalent director Shair sells over $2.4 million in company stock - Investing.com

Nuvalent Inc [NUVL] Director makes an insider sale of 37500 shares worth $2.61 million. – Knox Daily - Knox Daily

Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 37,500 Shares of Stock - MarketBeat

Analysts Issue Forecasts for Nuvalent, Inc.'s Q1 2025 Earnings (NASDAQ:NUVL) - MarketBeat

(NUVL) Technical Pivots with Risk Controls - Stock Traders Daily

Victory Capital Management Inc. Lowers Stake in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Analysts Set Nuvalent, Inc. (NASDAQ:NUVL) PT at $90.78 - MarketBeat

Nuvalent, Inc. (NASDAQ:NUVL) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 ... - Morningstar

Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 37,500 Shares of Stock - MarketBeat

Nuvalent director Shair sells over $2.6 million in stock - Investing.com India

Nuvalent director Shair sells over $2.6 million in stock - Investing.com

Why Earnings Season Could Be Great for Nuvalent (NUVL) - Yahoo Finance

Why Earnings Season Could Be Great for Nuvalent (NUVL) - Zacks Investment Research

Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Director Sells 37,500 Shares of Stock - MarketBeat

Deborah Ann Miller Sells 3000 Shares of Nuvalent, Inc. (NASDAQ:NUVL) Stock - Defense World

Nuvalent's chief legal officer sells over $200k in shares - Investing.com Australia

Nuvalent's chief legal officer sells over $200k in shares - Investing.com Australia

(NUVL) Investment Report - Stock Traders Daily

Insider Selling: Nuvalent, Inc. (NASDAQ:NUVL) Insider Sells 3,000 Shares of Stock - MarketBeat

It makes sense and dollars to buy Nuvalent Inc (NUVL) stock – Sete News - SETE News

Nuvalent director Shair sells over $2.6 million in company stock - Investing.com India

Nuvalent director Shair sells over $2.6 million in company stock - Investing.com Canada

Insider Selling: Shair Matthew, Nuvalent Inc [NUVL] Director divested 37500 shares – Knox Daily - Knox Daily

(NUVL) Trading Report - Stock Traders Daily

Nuvalent Inc (NUVL) rating initates by Jefferies – Knox Daily - Knox Daily

Nuvalent Inc (NUVL) presents a great opportunity, but the stock is slightly undervalued – US Post News - US Post News

Jefferies bullish on Nuvalent stock, cites strong Phase 1 NSCLC trial results - Investing.com Nigeria

Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1 ... - PR Newswire

ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors - Barron's

Nuvalent director Matthew Shair sells over $2.8 million in company stock - Investing.com UK

Nuvalent director Matthew Shair sells over $2.8 million in company stock - Investing.com

Chief Legal Officer Deborah Miller Sells 22,000 Shares of Nuvalent Inc (NUVL) - Yahoo Finance

Director Emily Conley Sells 13,333 Shares of Nuvalent Inc (NUVL) - Yahoo Finance

S&P 500 Futures Climb in Premarket Trading; CrowdStrike Holdings, MicroStrategy Lead - Barron's

Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor ... - PR Newswire

Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full ... - Yahoo Finance

NUVL과 유사한 종목